Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Billard

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Head & Neck|April 17, 2001
Surgical management of posterior pharyngeal wall carcinomas: functional and oncologic resultsM Julieron, F Kolb, G Schwaab, et al.
The British Journal of Surgery|August 12, 2008
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapyD Elias, C Honoré, R Ciuchendéa, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humansV Billard, P L Gambus, J Barr, et al.
European Journal of Biochemistry|August 15, 1989
Structure and activity of proteins from pathogenic fungi Phytophthora eliciting necrosis and acquired resistance in tobaccoP Ricci, P Bonnet, J C Huet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2014
Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal originD Elias, A Mariani, A-S Cloutier, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteersP L Gambús, T W Schnider, C F Minto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and toleranceD Elias, T Matsuhisa, L Sideris, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Cell Death & Disease|March 20, 2026
NSUN2 mediates intestinal stem cell expansion and colorectal tumour initiation via MAPK/ERK signallingAslihan Bastem Akan, Caroline V Billard, Szu-Ying Chen, et al.
Oncogene|September 6, 2024
Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expressionAntonia M D Churchhouse, Caroline V Billard, Toshiyasu Suzuki, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Head & Neck|April 17, 2001
Surgical management of posterior pharyngeal wall carcinomas: functional and oncologic resultsM Julieron, F Kolb, G Schwaab, et al.
The British Journal of Surgery|August 12, 2008
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapyD Elias, C Honoré, R Ciuchendéa, et al.
British Journal of Clinical Pharmacology|October 1, 1995
The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humansV Billard, P L Gambus, J Barr, et al.
European Journal of Biochemistry|August 15, 1989
Structure and activity of proteins from pathogenic fungi Phytophthora eliciting necrosis and acquired resistance in tobaccoP Ricci, P Bonnet, J C Huet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 4, 2014
Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal originD Elias, A Mariani, A-S Cloutier, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteersP L Gambús, T W Schnider, C F Minto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and toleranceD Elias, T Matsuhisa, L Sideris, et al.
Anesthesiology|January 1, 1997
Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model developmentC F Minto, T W Schnider, T D Egan, et al.
Cell Death & Disease|March 20, 2026
NSUN2 mediates intestinal stem cell expansion and colorectal tumour initiation via MAPK/ERK signallingAslihan Bastem Akan, Caroline V Billard, Szu-Ying Chen, et al.
Oncogene|September 6, 2024
Loss of DOCK2 potentiates Inflammatory Bowel Disease-associated colorectal cancer via immune dysfunction and IFNγ induction of IDO1 expressionAntonia M D Churchhouse, Caroline V Billard, Toshiyasu Suzuki, et al.
Pageof 6